KCM
EDIT icon

Kennedy Capital Management’s Editas Medicine EDIT Stock Holding History

Kennedy Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Buy
1,052,457
+490,317
+87% +$1.04M 0.06% 394
2025
Q4 		$1.15M Sell
562,140
-3,501
-0.6% -$10.1K 0.02% 469
2025
Q3 		$1.96M Sell
565,641
-1,978
-0.3% -$5.52K 0.04% 450
2025
Q2 		$1.25M Buy
567,619
+40,879
+8% +$66.9K 0.03% 484
2025
Q1 		$611K Sell
526,740
-2,096
-0.4% -$3.08K 0.01% 570
2024
Q4 		$672K Sell
528,836
-11,299
-2% -$28.8K 0.01% 625
2024
Q3 		$1.84M Buy
540,135
+407,487
+307% +$1.77M 0.04% 527
2024
Q2 		$619K Sell
132,648
-566
-0.4% -$3.19K 0.01% 628
2024
Q1 		$988K Buy
+133,214
New +$1.11M 0.02% 621

Other funds holding EDIT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return